Endovia Health Sciences (EDVA) vs Valion Bio (VBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Valion Bio is the larger company by market cap ($2.0 million vs $1.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | EDVA | VBIO |
|---|---|---|
| Share price | $0.1599 | $2.21 |
| Market cap | $1.77M | $1.96M |
| 1-day change | -3.09% | +0.91% |
| EPS (TTM) | $-21.94 | $-177.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.40 | $76.50 |
| 52-week low | $0.15 | $2.05 |
| Distance from 52-week high | -98.81% | -97.11% |
| Average volume | 4.50M | 1.46M |
| Shares outstanding | 11.08M | 887.59K |
| Employees | 1 | 52 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Endovia Health Sciences
EDVA stock →Endovia Health Sciences, Inc. develops a diversified cannabinoid health sciences platform that translates science into regulated therapies and trusted health and wellness products for people and animals in Ireland, United Kingdom, Australia, and Latin America.
Healthcare · Biotechnology · 1 employees
About Valion Bio
VBIO stock →Valion Bio, Inc. operates as a late-stage biopharmaceutical company.
Healthcare · Biotechnology · 52 employees
EDVA vs VBIO FAQ
Which is bigger, Endovia Health Sciences or Valion Bio?
Valion Bio (VBIO) is larger, with a market capitalization of $1.96M compared with $1.77M for Endovia Health Sciences (EDVA).
Are Endovia Health Sciences and Valion Bio in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.